Skip to main content

Table 1 Percent of total cells that stain strongly for CD163

From: Macrophage type 2 differentiation in a patient with laryngeal squamous cell carcinoma and metastatic prostate adenocarcinoma to the cervical lymph nodes

Specimen CD163 Level
Benign parotid lymph node 1 4.79%
Benign parotid lymph node 2 13.61%
Benign parotid lymph node 3 37.84%
Benign parotid lymph node 4 10.08%
Benign parotid lymph node 5 10.01%
Benign parotid lymph node 6 26.93%
Benign parotid lymph node 7 18.84%
Benign parotid lymph node 8 12.84%
Benign parotid lymph node 9 23.33%
Benign parotid lymph node 10 29.16%
Benign parotid lymph node 11 14.78%
Benign parotid lymph node 12 8.52%
Average benign parotid lymph node 17.56%
Negative draining lymph node 62.94%
Lymph node with metastatic focus of prostate adenocarcinoma 42.91%
Primary tumor 50.46%